The Neuroscience of SUMOylation: Modulating Synaptic Strength

In the brain, the ability to strengthen or weaken connections between neurons—synaptic plasticity—is the cellular basis for learning and memory. While phosphorylation and ubiquitination are well-known regulators of this process, another post-translational modification is emerging as a critical player: SUMOylation.

What is SUMOylation?

SUMOylation involves the covalent attachment of Small Ubiquitin-like Modifier (SUMO) proteins to specific lysine residues on target proteins. Unlike ubiquitination, which often marks proteins for degradation, SUMOylation typically alters a protein's localization, stability, or interaction with other partners.

Regulation of Synaptic Proteins

The synaptic proteome is rich with SUMO targets. By modifying proteins at both the presynaptic and postsynaptic terminals, SUMOylation can rapidly tune synaptic transmission.

1. Presynaptic Regulation: SUMOylation of proteins involved in the neurotransmitter release machinery, such as synaptotagmin and RIM1, can influence the probability of vesicle release. Research suggests that SUMOylation of RIM1 is essential for its interaction with calcium channels, thereby facilitating efficient neurotransmitter discharge.
2. Postsynaptic Regulation: At the postsynaptic density, SUMOylation regulates the trafficking of ionotropic receptors. For instance, the SUMOylation of GluK2 subunits of kainate receptors promotes their internalization, effectively reducing synaptic strength.

Impact on Long-Term Potentiation (LTP)

Long-Term Potentiation (LTP) is a persistent increase in synaptic strength following high-frequency stimulation. SUMOylation has been shown to be required for certain forms of LTP.

During LTP induction, there is a transient increase in the SUMOylation of nuclear transcription factors and cytosolic signaling proteins. This modification may help coordinate the complex protein synthesis and structural changes necessary to "lock in" the enhanced synaptic connection. Conversely, de-SUMOylation (mediated by SENP enzymes) is equally important for resetting the system and maintaining homeostatic balance.

SUMOylation and Neurological Disease

Given its central role in synaptic function, it is not surprising that dysregulated SUMOylation is linked to neurological disorders. In Alzheimer’s disease, changes in the SUMOylation of amyloid precursor protein (APP) and tau may influence the production of toxic aggregates. Furthermore, global changes in SUMO levels are observed during ischemia (stroke), where SUMOylation appears to be a protective response to cellular stress.

Conclusion

SUMOylation provides a rapid and reversible way for neurons to modify their proteome in response to activity. As we continue to identify new synaptic SUMO targets, it becomes clear that this modification is a fundamental pillar of neuronal communication and plasticity.